Product Information
CIPRO 10% SUSPENSION is a brand product labeled by Bayer HealthCare Pharmaceuticals Inc., priced at $1.4553 per ML under NDC 50419077301. Its NADAC has been published 658 times since Nov 28, 2013.
FDA first approved this application on Sep 26, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Bayer HealthCare Pharmaceuticals Inc.NDC
50419077301
Classification
Brand
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
New Drug (NDA)
FDA Application
NDA020780FDA Approved
9/26/1997
TE Code
AB
On Market Since
9/26/1997
Price Statistics
The NADAC for CIPRO 10% SUSPENSION has been published 658 times since Nov 28, 2013, and over the history we have for it it has risen 23.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4553 per ML |
|---|---|
| All-time high | $1.4806 (Jan 15, 2020) |
| All-time low | $1.1750 (Nov 28, 2013) |
| 52-week high | $1.4588 |
| 52-week low | $1.4552 |
| Median price | $1.4552 |
| Average price | $1.4045 |
| Largest weekly change | +9.9% (Mar 12, 2014) |
| Weeks tracked | 658 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bayer HealthCare Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ciprofloxacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CIPRO 10% SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for CIPRO 10% SUSPENSION, manufactured by Bayer HealthCare Pharmaceuticals Inc., is $1.4553 per ML (NDC 50419077301), effective Sep 30, 2026.
How has the price of CIPRO 10% SUSPENSION changed over time?
Over the history we have for it, the NADAC for CIPRO 10% SUSPENSION has risen 23.9%. It has been tracked across 658 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CIPRO 10% SUSPENSION?
Since Nov 28, 2013, the NADAC for CIPRO 10% SUSPENSION has ranged from a low of $1.1750 (Nov 28, 2013) to a high of $1.4806 (Jan 15, 2020), with a median of $1.4552 per ML.
Are there cheaper alternatives to CIPRO 10% SUSPENSION?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CIPRO 5% SUSPENSION, is $1.2486 per ML — about 14% below CIPRO 10% SUSPENSION.
Who manufactures CIPRO 10% SUSPENSION?
CIPRO 10% SUSPENSION (NDC 50419077301) is labeled by Bayer HealthCare Pharmaceuticals Inc., and CMS classifies it as a brand product.